Thought regenerating tissue was just for salamanders? It turns out that humans can regenerate certain tissues faster than others too.
A study authored by Duke researchers found that humans have the ability to regenerate cartilage in certain joints, though some are faster than others. These findings could potentially lead to new treatments for osteoarthritis, one of the worlds most common diseases.
The study, which included research going back more than a decade, outlined the discovery of an age gradient for different types of cartilage in humans. The researchers examined protein modifications and discovered that ankle cartilage had a higher rate of production than cartilage in the knees or hips.
That was a big surprise because most people think that all cartilage is the samesame proteins, same everything, said Professor of Medicine Virginia Kraus, the senior author of the study. We expected to be able to see a different turnover of different proteins, but the fact that it was changing by location, that was really surprising.
To contextualize these findings, Kraus and Ming-Feng Hsueh, a medical instructor in the department of orthopedic surgery and the studys lead author, went back millions of years to the evolution of a small lizard-like amphibian: the salamander. Salamanders are noteworthy in the animal kingdom due to their ability to completely regenerate lost limbsan ability that is shared by only a few other animals, such as zebrafish.
A study published in 2016 found that salamanders, zebrafish and another limb-regenerating type of freshwater fishall of which were separated by millions of years of evolutionhad essentially the same mechanisms for joint repair.
These mechanisms worked more effectively in repairing the parts of limbs that were closer to the torso compared to those that were farther away. This was a direct parallel to humans seemingly being able to repair cartilage in ankles much faster and more easily than in hips.
To Kraus and Hsueh, this signified that these regeneration mechanisms could be the same ones present in humans. This hypothesis was further bolstered by reports of children who could regenerate the distal parts of their fingertips. However, researchers dont know why or how this ability is turned off.
Limb regeneration is highly complex, Kraus said. Just looking back at [salamanders and zebrafish] with a fresh eye and trying to say, What is it about that process that we either share or we dont share? is how maybe we might be able to gain insights into what is lacking [in humans].
In fact, they found that this innate regenerative capability likely does exist in people.
From our study, we think that humans still have the ability [to regenerate limbs] or at least repair them to some level, Hsueh said. We think that the key factors to doing this are either missing or insufficient in humans. Our strategy for the future is to try to find the key factors that humans do not have enough of.
The factors that regulate the process of joint repair are known as microRNA. Hsueh explained that the answer to increasing repairability in joints afflicted by osteoarthritis is locating the microRNA that is in high abundance in ankles and increasing its level in other joints, such as the hip.
Signup for our editorially curated, weekly newsletter. Cancel at any time.
However, beyond increasing the amount of beneficial microRNA, Kraus and Hseuh also noted that it is necessary to identify and turn off bad microRNA, which may inhibit collagen production and thus aggravate osteoarthritis. Just like every other system in the body, joint repair is about balance.
This study may lead to new ways of treating osteoarthritis, which occurs when the cartilage at the ends of bones wears down. It can cause severe joint pain, swelling and stiffness, and currently affects an estimated 27 million Americans as of 2018.
Kraus said that unlike rheumatoid arthritis, which has treatments to prevent the disease as well as put it into remission, there are currently no existing effective treatments for osteoarthritis.
Contrary to popular belief, osteoarthritis isnt just a geriatric disease.
We know that 50% of people who get an anterior cruciate ligament tear will get osteoarthritis at a young age. So any time I watch the Duke basketball team and somebody goes down, Im like this is terrible, Kraus said. They have a one in two chance of developing osteoarthritis in just a few years.
Kraus and Hsuehs short-term goal is to help boost cartilage repair in patients with osteoarthritis, sports injuries and amputated limbs. In the long term, they hope to eradicate osteoarthritis entirely.
I think [in 50 years] well be in an enviable position in the way rheumatoid arthritis is thought of now, Kraus said. I think therell be early identification, well have really robust treatments, [and] joint replacements will be rare. I think well treat joint injuries very seriously the way heart attacks are treatedimmediately, with something really effective.
The researchers said funding is the biggest problem going forward. Most of the support for the study came from the National Institutes of Health, but according to Hsueh, who has been working on the study since he was a graduate student, obtaining grants is constantly an uphill battle.
Its breaking new ground and its really hard to get old thinking to change, Kraus said. Its a hard sell.
Kraus and Hsueh believe there is much work that can be done outside the field of rheumatology and orthopedics to contribute to these advancements, including collaborating with developmental scientists, experts in salamanders and specialists in regenerative medicine.
By putting the right brains together so that theres more crosstalk, that would really facilitate the advancements, Kraus said. Thats the future.
Originally posted here:
Regeneration race: Cartilage regrows faster in some joints than others - Duke Chronicle
- Stem Cells Applications in Regenerative Medicine and Disease ... - December 6th, 2024
- Ageing of stem cells reduces their capacity to form tumours - Nature.com - December 6th, 2024
- Master of Science in Regenerative Medicine and Entrepreneurships FUSION program information session - The Daily | Case Western Reserve University - December 6th, 2024
- BioRestorative Therapies Announces Notice of Allowance of - GlobeNewswire - December 6th, 2024
- Stem Cell Therapy Strategic Business Report 2024 - - GlobeNewswire - December 6th, 2024
- University of Colorado Anschutz Medical Campus-Led Team Receives Up to $46 Million to Develop Innovative Treatment to Cure Blindness - University of... - December 6th, 2024
- Affimed Announces Acimtamig and AlloNK Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug... - December 6th, 2024
- Navigating the hope and hype of regenerative medicine - October 14th, 2024
- Cell and Gene Therapy Investment Ticks Up After Hard Few Years - BioSpace - October 14th, 2024
- Crackdowns on Unproven Stem Cell Therapies Worked Abroad - Medpage Today - October 14th, 2024
- How Regenerative Medicine can help you get out of pain without surgery - WJLA - October 14th, 2024
- Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care... - October 14th, 2024
- Buy, Sell, Hold: Cell and Gene Therapy - BioPharm International - October 14th, 2024
- Mayo Clinic offers unique regenerative medicine procedure for knee and ... - September 13th, 2024
- Regenerative Medicine to the Rescue - Cleveland Clinic - September 13th, 2024
- Regenerative medicine applications: An overview of clinical trials - September 13th, 2024
- The Progression of Regenerative Medicine and its Impact on Therapy ... - September 13th, 2024
- Immune cell injection significantly boosts healing of bone, muscle & skin - September 13th, 2024
- Regenerative Medicine Foundation - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT ... - September 13th, 2024
- Tissue engineering and regenerative medicine approaches in colorectal ... - September 13th, 2024
- Tubular scaffolds boost stem cell-driven bone regeneration in skull defects - Phys.org - September 13th, 2024
- Finding the right path(way) to reduce fat accumulation in the liver - Medical University of South Carolina - September 13th, 2024
- NAMRU EURAFCENT Signs Agreement with Egypt Center for Research and Regenerative Medicine - DVIDS - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT) Designation for BBP-812 Canavan Disease Gene Therapy Program - StockTitan - September 13th, 2024
- BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and... - September 13th, 2024
- Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate - Yahoo Finance - September 13th, 2024
- Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets - Nature.com - September 13th, 2024
- Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) - Business Wire - September 13th, 2024
- HepaTx Enters Collaboration with Mayo Clinic to Advance Cell Therapy Technology for Liver Disease to Clinical Trials - Longview News-Journal - September 13th, 2024
- Obsidian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OBX-115 for the Treatment of Advanced Melanoma -... - September 4th, 2024
- Regenerative Medicine in Orthopedic Surgery: Expanding Our Toolbox - Cureus - September 4th, 2024
- Somite.ai takes pre-seed to $10M as it eyes to become the OpenAI of stem cell biology - CTech - September 4th, 2024
- Longeveron Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B in Hypoplastic Left Heart Syndrome (HLHS) - Yahoo... - September 4th, 2024
- Study Explores Potential Of 3D Printed Regenerative Breast Implants - Forbes - September 4th, 2024
- Nikon Announces New Image Analysis Functions to Empower Drug Discovery Research for Cancer, Neurological Disease, and Regenerative Medicine - PR... - September 4th, 2024
- Trinity researcher scores 800,000 to boost regenerative medicine - SiliconRepublic.com - September 4th, 2024
- Seeing the future: Zebrafish regenerates fully functional photoreceptor cells and restores its vision - EurekAlert - September 4th, 2024
- Regenerative Medicine Industry Projected to Surge to USD 73,084.2 Million by 2033, Growing at an 18.5% CAGR - Future Market Insights - September 4th, 2024
- What is regenerative medicine? | Northwell Health - July 2nd, 2024
- Science Saturday: A regenerative reset for aging - July 2nd, 2024
- Science Saturday: A year of new directions and advancements for ... - March 29th, 2024
- Diverse ways regenerative medicine is advancing health care - March 29th, 2024
- Stem cell-based regenerative medicine - PMC - National Center for ... - February 27th, 2024
- Regenerative medicine | NIST - February 10th, 2024
- San Jose blood stem cell donor meets 15-year-old whose life he saved in Los Angeles - The Mercury News - May 17th, 2023
- Regenerative medicine: Current therapies and future directions - April 23rd, 2023
- What Is Regenerative Medicine? | Goals and Applications | ISCRM - April 23rd, 2023
- Important Patient and Consumer Information About Regenerative Medicine ... - April 23rd, 2023
- Regenerative medicine can be a boon for those with Drug-Resistant Tuberculosis - Hindustan Times - April 23rd, 2023
- About Regenerative Medicine - Center for Regenerative ... - Mayo Clinic - April 7th, 2023
- Regenerative Medicine | National Institutes of Health (NIH) - April 7th, 2023
- Porcine Vaccine Market is estimated to be US$ 4.41 billion by 2030 with a CAGR of 7.50%during the forecast - EIN News - April 7th, 2023
- Advancing Safe and Effective Regenerative Medicine Products - March 21st, 2023
- Active Wound Care Market Rising demand for Skin Substitutes to boost the industry (2023-2033) | CAGR of 5.5% - EIN News - March 21st, 2023
- Veterinary Orthopedic Implants Market is estimated to be 421.3 Million by 2029 with a CAGR of 5.3% - By PMI - EIN News - March 21st, 2023
- ASKA Pharmaceutical : February 7 2023 EME and ASKA Announce Collaboration Agreement on Creating Novel PharmaLogical VHH to address an unmet medical... - February 8th, 2023
- A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field - Yahoo Finance - October 15th, 2022
- The Switch to Regenerative Medicine - Dermatology Times - October 15th, 2022
- The Alliance for Regenerative Medicine Announces Election of 2023 Officers, Executive Committee, and Board of Directors - GlobeNewswire - October 15th, 2022
- Mathematical model could bring us closer to effective stem cell therapies - Michigan Medicine - October 15th, 2022
- 'We have to find a way': FDA seeks solutions to aid bespoke gene therapy - BioPharma Dive - October 15th, 2022
- American Academy of Stem Cell Physicians to Offer Licensed Physicians Board Examination in Regenerative Medicine - GlobeNewswire - October 15th, 2022
- Discover Medical Advances in Cellular Therapy Research Using Cord Blood for Cancer, HIV, Cerebral Palsy and Autism During World Cord Blood Day 2022 -... - October 15th, 2022
- The Risk-Reward Proposition for CGT Clinical Trials - Applied Clinical Trials Online - October 15th, 2022
- Cell therapy weekly: Ray Therapeutics and Forge Biologics expand partnership - RegMedNet - October 15th, 2022
- FDA Expands Oversight of Cell and Gene Therapies - Pharmaceutical Technology Magazine - October 15th, 2022
- Frequency Therapeutics Completes Enrollment of Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss - Business Wire - October 15th, 2022
- The Health Benefits Of Sea Moss, According To Experts - Forbes - October 15th, 2022
- ProKidney Announces Multiple Abstracts Selected for Presentation at the American Society of ... - The Bakersfield Californian - October 15th, 2022
- Pain Management & Regenerative Medicine Specialists DFW - September 4th, 2022
- Tissue Engineering and Regenerative Medicine - National Institute of ... - September 4th, 2022
- First U.S. patient receives autologous stem cell therapy to treat dry AMD - National Institutes of Health (.gov) - September 4th, 2022
- International Stem Cell and Regenerative Medicine Research and Therapeutic Center in Egypt - Construction Review - September 4th, 2022
- Regenerative Medicine Market to Garner Bursting Revenues [+USD 27.29 Billion] with Top Growing Companies During 2022-2029 - eTurboNews | eTN - September 4th, 2022
- Immusoft Takes First-Ever Engineered B Cell Therapy into Clinic - BioSpace - September 4th, 2022
- Addressing Diversity Barriers to Regenerative Medicine Free Press of Jacksonville - Jacksonville Free Press - September 4th, 2022
- TikoMed's ILB mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all... - September 4th, 2022
- Frequency Therapeutics to Participate in September Investor and Medical Conferences - Business Wire - September 4th, 2022
- Can the immortal jellyfish teach us how to reverse aging? - Earth.com - September 4th, 2022